1061 — Essex Bio-Technology Share News
0.000.00%
- HK$1.15bn
- HK$693.22m
- HK$1.81bn
Brief: Essex Bio-Technology Posts HY Profit Of HK$110.7 MLN
Brief: Essex Bio-Technology Expects 10% Revenue And 30% Profit Decrease For HY
Brief: Shanghai Henlius Biotech Says Phase 3 Study Of HLX04-O For WAMD Meets Primary Endpoint
Brief: Essex Bio-Technology Posts Final Dividend Of HK$0.07 Per Share
Brief: Essex Bio-Technology's Unit Enters Exclusive Distribution Agreement With Osteopore International
Brief: Essex Bio-Technology's unit Receives Approval For Commercialisation Of Multi-Dose Sodium Hyaluronate Eye Drops From NMPA
Brief: Essex Bio-Technology To Declare Interim Dividend HK$0.07 Per Share
Brief: Essex Bio-Technology Says Biologics License Application Accepted For Wet-AMD Treatment
Brief: Essex Bio-Technology Gets Approval For Multi-Dose Diquafosol Sodium Eye Drops In PRC
Brief: Essex Bio-Technology Proposes Final Dividend Of HK$0.06 Per Ordinary Share
Brief: Essex Bio-Technology Says Approval To Commercialise Eye Drops From NMPA
Brief: Essex Bio-Technology Gets Approval To Commercialise Eye Drops In PRC
Brief: Essex Bio-Technology Declares Interim Dividend Of HK$0.06 Per Ordinary Share
Brief: Essex Bio-Technology Posts H1 Net Income Of HKD157.4 Mln
Brief: Essex Bio-Technology Says Got Approval To Commercialise Diquafosol Sodium Eye Drops In PRC
Brief: Essex Bio-Technology Says Final Dividend Of HK$0.045 Per Share
Brief: Essex Bio-Technology Says HY Profit HK$169.8 Mln
Brief: Essex Bio-Technology Announces Early Repayment Of Loan Facility
Brief: Essex Bio-Technology Proposes Final Dividend Of HK$0.025 Per Ordinary Share